Biogen (BIIB) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$0.35.
- Biogen's EPS (Weighted Average and Diluted) fell 11912.57% to -$0.35 in Q4 2025 from the same period last year, while for Dec 2025 it was $8.79, marking a year-over-year decrease of 2144.77%. This contributed to the annual value of $8.79 for FY2025, which is 2137.75% down from last year.
- Latest data reveals that Biogen reported EPS (Weighted Average and Diluted) of -$0.35 as of Q4 2025, which was down 11912.57% from $3.17 recorded in Q3 2025.
- In the past 5 years, Biogen's EPS (Weighted Average and Diluted) registered a high of $7.84 during Q3 2022, and its lowest value of -$0.68 during Q4 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $2.68 (2023), whereas its average is $2.81.
- Per our database at Business Quant, Biogen's EPS (Weighted Average and Diluted) tumbled by 13099.32% in 2021 and then surged by 66595.74% in 2024.
- Biogen's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.68 in 2021, then surged by 663.21% to $3.83 in 2022, then tumbled by 55.34% to $1.71 in 2023, then rose by 7.02% to $1.83 in 2024, then crashed by 119.13% to -$0.35 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.35 in Q4 2025, compared to $3.17 in Q3 2025 and $4.33 in Q2 2025.